E-drug: RFI: Ramsey Pricing of Pharmaceuticals
---------------------------------------------
I was wondering if anyone out there had thought about the feasibility
of eventual Ramsey pricing of pharmaceuticals in developing
countries. Ramsey pricing is when a firm sells at marginal costs to
those
countries that can't afford to pay any more for a product.
My questions:
1) What do you think the biggest impediments would be to implementing
such a system? Unregulated parallel exporting (for example)?
2) Would the marginal cost still be too high? Is there good data out
there about this topic?
3) If monitoring is needed to assure that the drugs are consumed by
those targeted in the receiving country, would setting up an
appropriate monitoring body be a good use of multi-lateral funds?
Should
the corporations contribute to it? Wasn't this the sticking point in
Malawi?
Any and all replies gladly welcomed.
Niels
--
J. Niels Rosenquist
MD/PhD Student
University of Pennsylvania School of Medicine
The Wharton School
Tel: +1-215-735-2032 - Home
Tel: +1-215-266-8388 - Cell
mailto:jrosenqu@mail.med.upenn.edu
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.